Several years of preliminary research results suggest chimeric antigen receptor (CAR) T-cell therapy could benefit pediatric patients with refractory systemic lupus erythematosus (SLE). The gene ...

SYNC, its first homegrown CAR-T therapy, one of the first to show promise in treating certain types of brain cancers. This ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

When translating your process into a GMP-compliant manufacturing protocol, it’s important to understand all the critical steps.

Cell Therapy Held Larger Share in Cell and Gene Therapy Market in 2023, full analysis by Product, Application, Source, Manufacturing, and Geography. NEW YORK, Oct. 30, 2024 /PRNewswire ...

Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...

Three investigators at Baylor College of Medicine’s (BCM) Center for Cell and Gene Therapy Institute (CAGT) have been awarded G-Rex Grants totaling $475,000 by ScaleReady, in collaboration with Wilson ...

This story was originally published on PharmaVoice. To receive daily news and insights, subscribe to our free daily ...

The death, which investigators linked to a preparatory chemo treatment rather than Beam's medicine, highlights the risks of using decades-old transplant drugs alongside cutting-edge CRISPR medicines.

Ocugen Inc ( (OCGN) ) has released its Q3 earnings. Here is a breakdown of the information Ocugen Inc presented to its investors. Ocugen, Inc.

In-depth interviews and an online survey found support for gene therapy as a treatment for inherited blood disorders, but ...